Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100

Revvity Inc. (RVTY) Current ratio

Alert me on Current ratio

Revvity Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.8×, up 0.1× from fiscal 2025 (1.7×). Over the past ten years it has ranged from 1.3× (fiscal 2017) to 3.6× (fiscal 2024); the current reading is higher than 36% of that period. That is below the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.7× (53.24%)
FY2024 3.6× 73.87%
FY2023 2.1× (2.82%)
FY2022 2.1× 5.88%
FY2021 2.0× 48.40%
FY2020 1.4× (24.79%)
FY2019 1.8× 12.61%
FY2018 1.6× 26.79%
FY2017 1.3× (36.02%)
FY2016 2.0× 7.18%

Quarterly newest first

Period Current ratio Change
Jun 2026 1.8× 4.77%
Mar 2026 1.7× 2.13%
Dec 2025 1.7× (4.04%)
Sep 2025 1.8× (47.33%)
42 more quarters

Against its own ten years

Low 1.3× High 3.6×
Ten-year median 1.8×
Current reading's percentile 36

Current ratio against peers

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on RVTY